SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-194801
Filing Date
2019-07-16
Accepted
2019-07-16 16:29:02
Documents
4
Period of Report
2019-07-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d778779d8k.htm 8-K 27819
2 EX-99.1 d778779dex991.htm EX-99.1 8471
3 GRAPHIC g778779xaratana001.jpg GRAPHIC 13564
4 GRAPHIC g778779xaratana002.jpg GRAPHIC 7083
  Complete submission text file 0001193125-19-194801.txt   66214
Mailing Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211
Business Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211 913.353.1000
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35952 | Film No.: 19957431
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1